Next Article in Journal
The Meiosis-Specific Crs1 Cyclin Is Required for Efficient S-Phase Progression and Stable Nuclear Architecture
Next Article in Special Issue
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
Previous Article in Journal
Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
IJMS
Volume 22
Issue 11
10.3390/ijms22115484
ijms-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement thumb_up
...
textsms
...
Article

Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript

by
Marta Colletti
1,*,†,
Angela Galardi
1,†,
Evelina Miele
1,
Virginia Di Paolo
1,
Ida Russo
1,
Cristiano De Stefanis
2,
Rita De Vito
3,
Martina Rinelli
4,
Andrea Ciolfi
5,
Biagio De Angelis
1,
Angelica Zin
6,
Alessandro Guffanti
7,
Maria Cristina Digilio
4,
Antonio Novelli
4,
Rita Alaggio
3,
Giuseppe Maria Milano
1 and
Angela Di Giannatale
1
1
Department of Pediatric Hematology/Oncology and Cell and Gene Therapy, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
2
Histology-Core Facility, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
3
Pathology Unit, Department of Laboratories, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
4
Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
5
Genetics and Rare Diseases Research Division, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
6
Institute of Pediatric Research Città Della Speranza and Laboratory of Solid Tumors, Clinic of Pediatric Hematology-Oncology, University of Padova, 35129 Padova, Italy
7
Nico Innovagroup S.r.l., 25125 Brescia, Italy
*
Author to whom correspondence should be addressed.
†
equal contribution.
Academic Editor: Gasparini Patrizia
Int. J. Mol. Sci. 2021, 22(11), 5484; https://doi.org/10.3390/ijms22115484
Received: 16 March 2021 / Revised: 17 May 2021 / Accepted: 18 May 2021 / Published: 22 May 2021
(This article belongs to the Special Issue Molecular, Genetic and Immunomodulatory Mechanisms in Soft Tissue Sarcoma)
View Full-Text Download PDF
Browse Figures

Abstract

Background: Spindle cell rhabdomyosarcoma (S-RMS) is a rare tumor that was previously considered as an uncommon variant of embryonal RMS (ERMS) and recently reclassified as a distinct RMS subtype with NCOA2, NCOA1, and VGLL2 fusion genes. In this study, we established a cell line (S-RMS1) derived from a four-month-old boy with infantile spindle cell RMS harboring SRF-NCOA2 gene fusion. Methods: Morphological and molecular characteristics of S-RMS1 were analyzed and compared with two RMS cell lines, RH30 and RD18. Whole genome sequencing of S-RMS1 and clinical exome sequencing of genomic DNA were performed. Results: S-RMS1 showed cells small in size, with a fibroblast-like morphology and positivity for MyoD-1, myogenin, desmin, and smooth muscle actin. The population doubling time was 3.7 days. Whole genome sequencing demonstrated that S-RMS1 retained the same genetic profile of the tumor at diagnosis. A Western blot analysis showed downregulation of AKT-p and YAP-p while RT-qPCR showed upregulation of endoglin and GATA6 as well as downregulation of TGFßR1 and Mef2C transcripts. Conclusion: This is the first report of the establishment of a cell line from an infantile spindle cell RMS with SRF-NCOA2 gene fusion. S-RMS1 should represent a useful tool for the molecular characterization of this rare and almost unknown tumor. View Full-Text
Keywords: spindle cell; rhabdomyosarcoma; SRF-NCOA2; cell line spindle cell; rhabdomyosarcoma; SRF-NCOA2; cell line
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

SciFeed

Share and Cite

MDPI and ACS Style

Colletti, M.; Galardi, A.; Miele, E.; Di Paolo, V.; Russo, I.; De Stefanis, C.; De Vito, R.; Rinelli, M.; Ciolfi, A.; De Angelis, B.; Zin, A.; Guffanti, A.; Digilio, M.C.; Novelli, A.; Alaggio, R.; Milano, G.M.; Di Giannatale, A. Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript. Int. J. Mol. Sci. 2021, 22, 5484. https://doi.org/10.3390/ijms22115484

AMA Style

Colletti M, Galardi A, Miele E, Di Paolo V, Russo I, De Stefanis C, De Vito R, Rinelli M, Ciolfi A, De Angelis B, Zin A, Guffanti A, Digilio MC, Novelli A, Alaggio R, Milano GM, Di Giannatale A. Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript. International Journal of Molecular Sciences. 2021; 22(11):5484. https://doi.org/10.3390/ijms22115484

Chicago/Turabian Style

Colletti, Marta, Angela Galardi, Evelina Miele, Virginia Di Paolo, Ida Russo, Cristiano De Stefanis, Rita De Vito, Martina Rinelli, Andrea Ciolfi, Biagio De Angelis, Angelica Zin, Alessandro Guffanti, Maria C. Digilio, Antonio Novelli, Rita Alaggio, Giuseppe M. Milano, and Angela Di Giannatale. 2021. "Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript" International Journal of Molecular Sciences 22, no. 11: 5484. https://doi.org/10.3390/ijms22115484

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Back to TopTop